NCT05148312View on ClinicalTrials.gov

Single-dose AQ001S PK Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

November 12, 2021

Primary Completion Date

December 24, 2021

Study Completion Date

February 21, 2022

Conditions
Pharmacokinetics
Interventions
DRUG

Budesonide Inhalant Product

Single-dose of budesonide solution administered by nebulization.

Trial Locations (1)

1612

MC Comac Medical Ltd., Sofia

Sponsors
All Listed Sponsors
lead

Aquilon Pharmaceuticals S.A.

INDUSTRY

NCT05148312 - Single-dose AQ001S PK Study in Healthy Volunteers | Biotech Hunter | Biotech Hunter